Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) is now available.
China Resources Pharmaceutical Group Ltd. announced the successful issuance of the first tranche of its 2025 corporate bonds in the PRC, amounting to RMB1.6 billion with a coupon rate of 1.92% per annum. The proceeds from this issuance will be utilized to repay interest-bearing debt, potentially enhancing the company’s financial stability and operational efficiency.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. operates within the pharmaceutical industry, focusing on the distribution and marketing of pharmaceutical products. The company serves the healthcare market by providing a wide range of products and services aimed at improving health outcomes.
YTD Price Performance: -6.62%
Average Trading Volume: 3,217
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €4.1B
For an in-depth examination of 3320 stock, go to TipRanks’ Stock Analysis page.